Endothelial cells: source, barrier, and target of defensive mediators.
Roumenina, Lubka T; Rayes, Julie; Frimat, Marie; Fremeaux-Bacchi, Veronique.
; 274(1): 307-329, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27782324
A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
Advances in our understanding of the pathogenesis of hemolytic uremic syndromes.
Genetic background of atypical hemolytic-uremic syndrome and its influence on the course of disease and therapeutic effects
Tromboticheskaia mikroangiopatiia glaza pri atipichnom gemolitiko-uremicheskom sindrome (klinicheskoe nabliudenie).
Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?
Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
The role of von Willebrand factor in thrombotic microangiopathy.
Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.
The clinical spectrum of hemolytic uremic syndrome secondary to complement factor H autoantibodies.
[Atypical HUS caused by complement-related abnormalities].